Stark A H, Switzer B R, Atwood J R, Travis R G, Smith J L, Ullrich F, Ritenbaugh C, Hatch J, Wu X
Lineberger Comprehensive Cancer Center, USA.
Nutr Cancer. 1998;31(2):138-42. doi: 10.1080/01635589809514693.
High dietary fiber intake has been hypothesized to lower blood estrogen concentrations, an effect thought to be beneficial for decreasing breast cancer risk. This study investigated the association between dietary supplementation of wheat bran and circulating estrogen levels in postmenopausal African-American women participating in a community intervention trial. Seventeen postmenopausal women (aged 63 +/- 1.6 yr) participated in the study. Nutritional status was assessed and blood and 24-hour urine samples were collected before and after five to six weeks of daily supplementation of the diet with 35 g of wheat bran cereal (11.6 g insoluble dietary fiber) marked with 28 mg of riboflavin. Riboflavin confirmed that all postmenopausal participants adhered to the intervention protocol. Nine of the 17 postmenopausal women were taking some form of estrogen replacement therapy (PM-ERT). Baseline hormone levels in the PM-ERT group did not significantly change after the dietary intervention. Estradiol (96.8 +/- 20.3 vs. 113.8 +/- 23.3 pg/ml), androstenedione (0.47 +/- 0.06 vs. 0.45 +/- 0.06 ng/ml), and sex hormone-binding globulin (SHBG, 107 +/- 13.5 vs. 106.6 +/- 13.3 nmol/l) levels remained constant. In the eight postmenopausal women who were not receiving exogenous hormones (PM), wheat bran consumption was not associated with predicted decreased levels of estradiol (25.7 +/- 2.7 vs. 31.0 +/- 1.9 pg/ml), estrone (38.3 +/- 10.1 vs. 39.3 +/- 10.6 pg/ml), and androstenedione (0.78 +/- 0.08 vs. 0.68 +/- 0.11 ng/ml) or with increased concentrations of SHBG (35.2 +/- 6.4 vs. 34.8 +/- 6.5 nmol/l). Participants receiving ERT had baseline and postintervention levels of estradiol and SHBG significantly higher and androstenedione significantly lower than those not receiving ERT. No association between wheat bran supplementation and hormone levels was found in PM or PM-ERT African-American participants. These results in postmenopausal women are in contrast to findings of earlier studies in premenopausal women indicating that wheat bran fiber decreases serum sex hormones. Estrogen levels in postmenopausal women are only 5-10% of those in premenopausal women; therefore, a high wheat bran fiber diet alone may not be sufficient to depress these low levels even further.
高膳食纤维摄入量被认为可以降低血液中雌激素浓度,这种作用被认为有利于降低患乳腺癌的风险。本研究调查了参与社区干预试验的绝经后非裔美国女性膳食补充麦麸与循环雌激素水平之间的关联。17名绝经后女性(年龄63±1.6岁)参与了该研究。在每日补充35克标记有28毫克核黄素的麦麸谷物(11.6克不溶性膳食纤维)五到六周前后,对营养状况进行了评估,并采集了血液和24小时尿液样本。核黄素证实所有绝经后参与者都遵守了干预方案。17名绝经后女性中有9名正在接受某种形式的雌激素替代疗法(PM-ERT)。膳食干预后,PM-ERT组的基线激素水平没有显著变化。雌二醇(96.8±20.3对113.8±23.3皮克/毫升)、雄烯二酮(0.47±0.06对0.45±0.06纳克/毫升)和性激素结合球蛋白(SHBG,107±13.5对106.6±13.3纳摩尔/升)水平保持不变。在8名未接受外源性激素的绝经后女性(PM)中,食用麦麸与预测的雌二醇水平降低(25.7±2.7对31.0±1.9皮克/毫升)、雌酮(38.3±10.1对39.3±10.6皮克/毫升)、雄烯二酮(0.78±0.08对0.68±0.11纳克/毫升)无关,也与SHBG浓度升高(35.2±6.4对34.8±6.5纳摩尔/升)无关。接受ERT的参与者的雌二醇和SHBG的基线水平及干预后水平显著高于未接受ERT的参与者,而雄烯二酮则显著低于未接受ERT的参与者。在非裔美国绝经后女性参与者(PM或PM-ERT)中未发现麦麸补充与激素水平之间的关联。绝经后女性的这些结果与早期对绝经前女性的研究结果相反,早期研究表明麦麸纤维可降低血清性激素水平。绝经后女性的雌激素水平仅为绝经前女性的5-10%;因此,仅高麦麸纤维饮食可能不足以进一步降低这些低水平。